Focus: Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say

Lower prices for weight-loss pills from Novo Nordisk and Eli Lilly are prompting patients to switch from compounded medications to branded Wegovy and Foundayo, according to Reuters interviews with nine U.S. doctors.
Open original source